Back to Clinical Trials Overview
Back To Cancer Clinical Trials
An Open-label Phase 2 Study of ACE-041 in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Principal Investigator(s): Marshall Posner
Randomized, double-blind, multicenter two-stage adaptive Phase 3 study of intravenous administration of Reolysin® (Reovirus Type 3 Dearing) in combination with Paclitaxel and Carboplatin versus the chemotherapy alone in patients with metastatic or recurrent squamous cell carcinoma of the head and neck who have progressed on or after prior platinum-based chemotherapy
Principal Investigator(s): Krzysztof J. Misiukiewicz
Back To Cancer Clinical Trials
Your search for "Larnyx" returned 2 results:
An Open-label Phase 2 Study of ACE-041 in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Principal Investigator(s): Marshall Posner
Randomized, double-blind, multicenter two-stage adaptive Phase 3 study of intravenous administration of Reolysin® (Reovirus Type 3 Dearing) in combination with Paclitaxel and Carboplatin versus the chemotherapy alone in patients with metastatic or recurrent squamous cell carcinoma of the head and neck who have progressed on or after prior platinum-based chemotherapy
Principal Investigator(s): Krzysztof J. Misiukiewicz
Contact Us
Office of Research Services (ORS)
Tel: 212-824-7294
Send e-mail
Related Resources
For Patients
- Find a Mount Sinai Doctor
- Find a Mount Sinai Department or Institute
- Research Match
- Clinicaltrials.gov
- National Cancer Clinical Trials
- Video - Participating in Research - You Can Be Part of the Answer
- The Center for Information & Study on Clinical Research Participation
- Patients Like Me
For Investigators
- Office of Research Services (ORS)
- How to Post Research Projects on the Website
- Conduits
- Research Information Technology
- Communicating with Research Subjects